Augmentation with naltrexone to treat compulsive sexual behavior: a case series
- PMID: 20196983
Augmentation with naltrexone to treat compulsive sexual behavior: a case series
Abstract
Background: Compulsive sexual behavior (CSB) is generally characterized by recurrent and intense sexually arousing fantasies, sexual urges, and behaviors, which cause individuals distress or impair daily functioning. Descriptive studies of individuals with paraphilic and nonparaphilic CSB indicate that they experience urges to engage in problematic sexual behavior. The opiate antagonist naltrexone has been successfully used to treat a number of disorders in which urges to engage in problematic behavior are a central feature, such as alcoholism. We hypothesized that naltrexone would reduce the urges and behaviors associated with CSB.
Methods: Records of 19 male patients with CSB who were treated with naltrexone at an outpatient adult sexual health clinic were retrospectively reviewed.
Results: Nearly all patients were already taking other psychotropic medications when naltrexone was initiated. Seventeen (89%) of the 19 patients reported a reduction in CSB symptoms when taking naltrexone for a period ranging from 2 months to 2.3 years, as judged by Clinical Global Impression scores of 1 or 2, indicating "very much improved" or "much improved." Five (26%) of the 19 patients chose to discontinue the medication.
Conclusions: Naltrexone may be a useful adjunctive treatment for CSB.
Similar articles
-
Assessment and treatment of compulsive sexual behavior.Minn Med. 2003 Jul;86(7):42-7. Minn Med. 2003. PMID: 12921375 Review.
-
Opioid antagonists in the treatment of impulse-control disorders.J Clin Psychiatry. 1998 Apr;59(4):159-64. J Clin Psychiatry. 1998. PMID: 9590665
-
Epidemiology, prevalence, and natural history of compulsive sexual behavior.Psychiatr Clin North Am. 2008 Dec;31(4):603-11. doi: 10.1016/j.psc.2008.06.005. Psychiatr Clin North Am. 2008. PMID: 18996301 Review.
-
Naltrexone in adults with intellectual disability improves compulsive and dissocial disorders: a case report.Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1137-8. doi: 10.1016/j.pnpbp.2010.05.003. Epub 2010 May 9. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 20460140 No abstract available.
-
Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: two case studies.Int Clin Psychopharmacol. 2002 Jul;17(4):201-5. doi: 10.1097/00004850-200207000-00008. Int Clin Psychopharmacol. 2002. PMID: 12131605
Cited by
-
Current Understanding of Compulsive Sexual Behavior Disorder and Co-occurring Conditions: What Clinicians Should Know about Pharmacological Options.CNS Drugs. 2024 Apr;38(4):255-265. doi: 10.1007/s40263-024-01075-2. Epub 2024 Mar 14. CNS Drugs. 2024. PMID: 38485889 Review.
-
The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder.Dialogues Clin Neurosci. 2022 Dec;24(1):10-69. doi: 10.1080/19585969.2022.2134739. Dialogues Clin Neurosci. 2022. PMID: 37522807 Free PMC article.
-
The Potential Cutaneous Effects of Pornography Addiction: A Narrative Review.Cureus. 2022 Dec 28;14(12):e33066. doi: 10.7759/cureus.33066. eCollection 2022 Dec. Cureus. 2022. PMID: 36721540 Free PMC article. Review.
-
A randomised controlled trial of fluoxetine versus naltrexone in compulsive sexual behaviour disorder: presentation of the study protocol.BMJ Open. 2022 Jun 3;12(6):e051756. doi: 10.1136/bmjopen-2021-051756. BMJ Open. 2022. PMID: 36691245 Free PMC article.
-
Treatments and interventions for compulsive sexual behavior disorder with a focus on problematic pornography use: A preregistered systematic review.J Behav Addict. 2022 Sep 9;11(3):643-666. doi: 10.1556/2006.2022.00061. Print 2022 Sep 26. J Behav Addict. 2022. PMID: 36083776 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
